A recent article in new scientist magazine suggests research undertaken by a joint team of scientists working in America and Israel, have had some success in helping with clients overcome suicidal thoughts. The participants in the study were given painkillers (buprenorphine). The research suggests that there is some improvement in people’s thinking.
In this small study carried out in the US, by this joint team, participants were given the painkiller buprenorphine, because the low risk this carries from an overdose, also, the doses were kept low to carry less risk to the participant. Preliminary results show that people improved their mood on pain relief medication and were able to cope adequately with life.
It is thought that buprenorphine act on a number of opioid receptors in the brain, scientists of unsure which receptors exactly, but there is a promise that giving suicidal patients buprenorphine, may stave off the thoughts of taking their own life’s.
As yet GPs, psychiatrists and mental health professionals have nothing to help clients with suicidal idealization. This research may help thousands of people in the UK. The idea of a pharmaceutical which patients with suicidal thoughts could take to quell these suicidal thoughts has been asked for over 20 years by mental health professionals. Although this research is in its infancy, it certainly shows promising’s signs.
According to the phone helpline charity, the Samaritans 4,722 people in the UK took their own life in 2013, with the largest figure being in the male population at 3,684.
Suicide biggest killer of men between the age of 18 and 34, according to the Samaritans figures.